Operation | No (%) | Age (years) | Euroscore | CPB (mins) | XClamp (mins) | Mortality |
---|---|---|---|---|---|---|
MVR | 15 (29.4%) | 33.2 ± 11.4 | 3.9 ± 1.3 | 145.5 ± 41.1 | 96.3 ± 20.6 | 2 |
MV Rep | 1 (2%) | 21 | 3 | 120 | 80 | 0 |
ASD | 14 (27.5%) | 28.9 ± 12.4 | 2.9 ± 0.9 | 86.5 ± 44.2 | 45.9 ± 29.8 | 1 |
VSD | 8 (15.7%) | 15.0 ± 9.4 | 3.9 ± 1.2 | 159.1± 77.3 | 108.9 ± 64.7 | 2 |
AVR | 5 (9.8%) | 23.8 ± 3.1 | 4.0 ± 1.4 | 156.8 ± 10.8 | 103.5 ± 20 | 0 |
Glenn | 2 (3.9%) | 13 ± 2.8 | 2.5 ± 0.7 | 97 ± 1.4 | N/A | 0 |
LA Myxoma | 2 (3.9%) | 60 ± 14.1 | 7 ± 4.3 | 132 ± 11.3 | 98 ± 2.8 | 1 |
TOF | 2 (3.9%) | 15.5 ± 13.4 | 2 | 267.5 ± 19.1 | 127 ± 15.6 | 2 |
CABG | 2 (3.9%) | 64 ± 11.3 | 10 ± 5.7 | 160 | 70 | 1 |
TOTAL | 51 | 9 |